tiprankstipranks
Advertisement
Advertisement

AU:LTP Stock Latest News

LTR Pharma Wins Ethics Nod for First GI Trial of Intranasal OROFLOW
Company AnnouncementsLTR Pharma Wins Ethics Nod for First GI Trial of Intranasal OROFLOW
3d ago
LTP
LTR Pharma sets first U.S. telehealth route to market for ROXUS
PremiumCompany Announcements
LTR Pharma sets first U.S. telehealth route to market for ROXUS
18d ago
LTP
LTR Pharma outlines limits and legal caveats in latest investor update
PremiumCompany Announcements
LTR Pharma outlines limits and legal caveats in latest investor update
2M ago
LTP
LTR Pharma Halts Trading Ahead of Interim SPONTAN Nasal Spray Trial Results
PremiumCompany Announcements
LTR Pharma Halts Trading Ahead of Interim SPONTAN Nasal Spray Trial Results
2M ago
LTP
LTR Pharma advances SPONTAN Phase II study and U.S. ED spray strategy
PremiumCompany Announcements
LTR Pharma advances SPONTAN Phase II study and U.S. ED spray strategy
2M ago
LTP
LTR Pharma issues cautionary investor update on non-offer presentation
PremiumCompany AnnouncementsLTR Pharma issues cautionary investor update on non-offer presentation
4M ago
LTP
LTR Pharma completes recruitment for key Phase II SPONTAN study
Premium
Company Announcements
LTR Pharma completes recruitment for key Phase II SPONTAN study
4M ago
LTP
LTR Pharma lodges half-year Appendix 4D report with ASX
Premium
Company Announcements
LTR Pharma lodges half-year Appendix 4D report with ASX
4M ago
LTP
LTR Pharma Seeks ASX Quotation for Additional 50,000 Shares
PremiumCompany Announcements
LTR Pharma Seeks ASX Quotation for Additional 50,000 Shares
5M ago
LTP
LTR Pharma Advances ED Nasal Spray Programs as SPONTAN Use Tops 1,000 Prescriptions
PremiumCompany Announcements
LTR Pharma Advances ED Nasal Spray Programs as SPONTAN Use Tops 1,000 Prescriptions
5M ago
LTP
LTR Pharma Begins Phase II Dosing for Intranasal Erectile Dysfunction Spray SPONTAN
PremiumCompany Announcements
LTR Pharma Begins Phase II Dosing for Intranasal Erectile Dysfunction Spray SPONTAN
5M ago
LTP
LTR Pharma Seeks ASX Quotation for Additional 82,508 Shares
PremiumCompany Announcements
LTR Pharma Seeks ASX Quotation for Additional 82,508 Shares
5M ago
LTP
LTR Pharma Issues 8.3 Million Unquoted Options Expiring in 2028
PremiumCompany AnnouncementsLTR Pharma Issues 8.3 Million Unquoted Options Expiring in 2028
5M ago
LTP
LTR Pharma Begins Phase II Recruitment for Intranasal Erectile Dysfunction Spray SPONTAN
Premium
Company Announcements
LTR Pharma Begins Phase II Recruitment for Intranasal Erectile Dysfunction Spray SPONTAN
5M ago
LTP
LTR Pharma’s SPONTAN Nasal Spray Data Wins Podium Slot at 2026 Sexual Medicine Congress
Premium
Company Announcements
LTR Pharma’s SPONTAN Nasal Spray Data Wins Podium Slot at 2026 Sexual Medicine Congress
6M ago
LTP
LTR Pharma Issues New Unquoted Performance Rights and Options Under Incentive Schemes
PremiumCompany Announcements
LTR Pharma Issues New Unquoted Performance Rights and Options Under Incentive Schemes
6M ago
LTP
LTR Pharma Achieves Milestone with SPONTAN® Prescriptions
PremiumCompany Announcements
LTR Pharma Achieves Milestone with SPONTAN® Prescriptions
6M ago
LTP
LTR Pharma Receives TGA Clearance for SPONTAN® Phase II Study
PremiumCompany Announcements
LTR Pharma Receives TGA Clearance for SPONTAN® Phase II Study
7M ago
LTP
LTR Pharma Advances SPONTAN® Phase II Clinical Study with Ethics Approval
PremiumCompany Announcements
LTR Pharma Advances SPONTAN® Phase II Clinical Study with Ethics Approval
7M ago
LTP
LTR Pharma to Release Securities from ASX Escrow, Enhancing Market Liquidity
PremiumCompany AnnouncementsLTR Pharma to Release Securities from ASX Escrow, Enhancing Market Liquidity
7M ago
LTP
LTR Pharma Director Acquires 1 Million Options Under Incentive Plan
Premium
Company Announcements
LTR Pharma Director Acquires 1 Million Options Under Incentive Plan
7M ago
LTP
LTR Pharma Limited Announces Change in Director’s Interest
Premium
Company Announcements
LTR Pharma Limited Announces Change in Director’s Interest
7M ago
LTP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >